Comparison of Putative BH3 Mimetics AT-101, HA14-1, Sabutoclax and TW-37 With ABT-737 in Platelets

Platelets - United Kingdom
doi 10.1080/09537104.2020.1724276
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

BCL-xL-Inhibitory BH3 Mimetics (ABT-737 or ABT-263) and the Modulation of Cytosolic Calcium Flux and Platelet Function

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

The BH3 Mimetic ABT-737 Increases Treatment Efficiency of Paclitaxel Against Hepatoblastoma

BMC Cancer
Cancer ResearchOncologyGenetics
2011English

The BH3 Mimetic Drug ABT-737 Induces Apoptosis and Acts Synergistically With Chemotherapeutic Drugs in Thyroid Carcinoma Cells

Cancer Cell International
Cancer ResearchOncologyGenetics
2016English

Human Pluripotent Stem Cells and Derived Neuroprogenitors Display Differential Degrees of Susceptibility to BH3 Mimetics ABT-263, WEHI-539 and ABT-199

PLoS ONE
Multidisciplinary
2016English

Preclinical Evaluation of Antiangiogenic Thrombospondin-1 Peptide Mimetics, ABT-526 and ABT-510, in Companion Dogs With Naturally Occurring Cancers

Clinical Cancer Research
Cancer ResearchOncology
2006English

BH3 Mimetics: Their Action and Efficacy in Cancer Chemotherapy

Integrative Cancer Science and Therapeutics
2016English

Synergistic BCL-2 Inhibition by ABT-737 and Cyclosporine A

Apoptosis : an international journal on programmed cell death
Cell BiologyPharmacologyBiochemistryClinical BiochemistryCancer ResearchPharmaceutical Science
2012English

Selective Elimination of Culture-Adapted Human Embryonic Stem Cells With BH3 Mimetics

Stem Cell Reports
BiochemistryGeneticsDevelopmental BiologyCell Biology
2018English

Glycolysis Inhibition Targets McL-1 to Restore Sensitivity of Lymphoma Cells to ABT-737-induced Apoptosis

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy